FDA’s Warn Risks Associated With Compounded Semaglutide

The use of pharmaceutical compounds to treat various medical conditions is becoming increasingly prevalent. However, some compounded medications may pose risks and potential hazards to patients. In this article, we will delve into the risks associated with compound semaglutide, taking into account the recent warning issued by the U.S. Food and Drug Administration (FDA). We will explore the role of semaglutide in diabetes treatment, the FDA’s approval process, and the specific concerns surrounding compounded forms of this medication.

What is Semaglutide?

Semaglutide is a medication used to treat type 2 diabetes mellitus. It belongs to the class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). These drugs work by mimicking the action of GLP-1, a hormone that helps regulate blood sugar levels.

Function of Semaglutide

When semaglutide is administered, it stimulates the release of insulin and reduces the production of glucagon in the pancreas. This process helps lower blood sugar levels and can lead to improved glycemic control in individuals with diabetes.

How Semaglutide is Administered?

FDA-approved semaglutide is available in injectable form and is typically self-administered once a week. Patients can easily administer the medication using a pre-filled pen-like device.

Importance of Semaglutide in Diabetes Treatment

Semaglutide has been hailed as a significant advancement in the management of type 2 diabetes. Clinical trials have shown that it can effectively reduce blood glucose levels and, in some cases, promote weight loss.

FDA’s Approval of Semaglutide

The FDA carefully evaluates medications before granting approval for public use. Semaglutide underwent rigorous testing to demonstrate its safety and efficacy in treating diabetes. The FDA approval process ensures that medications meet high standards of quality and that their benefits outweigh potential risks.

FDA’s Warning on Compound Semaglutide

Recently, the FDA issued a warning regarding compound semaglutide. Compounding refers to the practice of creating a medication by mixing individual ingredients. While FDA-approved semaglutide has undergone rigorous testing, compounded versions may not have undergone the same level of scrutiny, potentially leading to unknown risks.

Understanding the Risks and Hazards

The risks associated with compound semaglutide arise from the lack of regulatory oversight. Compounded Semaglutide may not adhere to the same strict manufacturing standards as pharmaceutical companies, potentially leading to variations in the medication’s potency, stability, or purity.

Common Side Effects of Compounded Semaglutide

FDA-approved semaglutide has known side effects, including nausea, vomiting, and diarrhea. These side effects are typically mild and tend to diminish with continued use. However, compounded semaglutide may pose additional risks due to the uncertainty surrounding its preparation.

Risks Associated with Compounded Semaglutide

Compounded medications can be beneficial in certain situations, such as when a patient has specific allergies or requires a unique dosage form. However, the lack of standardization in compounding can lead to inconsistent results and potentially compromise patient safety.

FDA Warns of Differences in Compounded Semaglutide

The FDA issued a warning recently regarding certain compounded forms of semaglutide, which may not contain the same active ingredient as the approved versions for type 2 diabetes and weight loss.

Supply Shortages and Compounded Versions

Unprecedented demand for the GLP-1 receptor agonist has led to supply shortages of injectable forms like Ozempic and Wegovy. Consequently, more and more Compounded Semaglutide of the drug are surfacing in the market. The FDA has received reports of adverse events associated with these formulations and compounders utilizing semaglutide sodium and semaglutide acetate.

Different Active Ingredients

It’s essential to understand that these salt forms of semaglutide differ from the approved drugs, which contain the base form of semaglutide. Products containing these salts, such as semaglutide sodium and semaglutide acetate, have not demonstrated safety and efficacy.

No Generic Form, but Compounded Forms

While there is no generic form of semaglutide available, Compounded Semaglutide can be produced for individual patients during a shortage. However, the FDA emphasizes that compounding a drug using semaglutide salts does not meet federal requirements.

APC’s Stance on Semaglutide Sodium

The Alliance for Pharmacy Compounding (APC) has also addressed the issue, stating that semaglutide sodium does not meet the criteria for compounding. It is not the active pharmaceutical ingredient (API) listed on the reference products’ labeling, nor does it appear on the FDA’s bulk compounding list or have a U.S. Pharmacopeia monograph.

Where to Obtain Semaglutide?

FDA recommends that patients with a semaglutide prescription should obtain the drug only from state-licensed pharmacies or outsourcing facilities registered with FDA. Purchasing medicine online from unregulated and unlicensed sources can expose patients to potentially unsafe products that have not undergone appropriate evaluation or approval.

Benefits of FDA-Approved Semaglutide

Opting for FDA-approved semaglutide offers several benefits. Patients can have confidence in the medication’s quality, as it has met the rigorous standards set by the FDA. Additionally, healthcare providers have access to detailed information about the medication’s safety and potential risks.

Dangers of Unregulated Compounding

Unregulated compounding poses significant dangers, especially when it comes to medications that require precise dosing, like semaglutide. Patients who opt for compounded versions may be exposed to unknown risks and uncertain outcomes.

FDA’s Role in Protecting Public Health

The FDA plays a critical role in protecting public health by regulating pharmaceuticals and ensuring their safety and efficacy. The agency monitors medications even after approval and takes action if any safety concerns arise.

Reporting Adverse Events

Any adverse events associated with compounded drugs should be reported to the MedWatch Adverse Event Reporting program.

Importance of Informed Consent

Patients have the right to make informed decisions about their healthcare. When it comes to medications, understanding the potential risks and benefits is crucial. Healthcare providers should fully inform patients about their treatment options, including the differences between FDA-approved and compounded medications.

FDA-Approved Semaglutide vs. Compounded Semaglutide

In summary, the use of compounded semaglutide carries inherent risks due to the lack of regulatory oversight and standardization. Opting for FDA-approved semaglutide provides patients with a safer and more predictable treatment option for managing type 2 diabetes.


While compounded medications may seem like an attractive alternative, the risks they pose, particularly in the case of semaglutide, should not be underestimated. Patients and healthcare providers should prioritize FDA-approved medications to ensure optimal safety and effectiveness in managing diabetes and other medical conditions.


How is semaglutide administered?

FDA-approved semaglutide is self-administered once a week using a pre-filled pen-like device.

What are the risks of compounded semaglutide?

Compounded semaglutide lacks the same level of regulation and oversight, leading to potential risks and uncertainties.

Are there side effects of semaglutide?

Common side effects of FDA-approved semaglutide include nausea, vomiting, and diarrhea.

Why is FDA approval important for medications like semaglutide?

FDA approval ensures that medications meet high safety and efficacy standards, minimizing potential risks to patients.


  1. U.S. Food and Drug Administration (FDA) – Information about drug approval and the regulatory process: Website: https://www.fda.gov/drugs/drug-information-consumers/fda-drug-safety-essentials
  2. American Diabetes Association – Information on diabetes medications, including the importance of FDA-approved treatments: Website: https://www.diabetes.org/
  3. Mayo Clinic – Information on diabetes medications and the importance of FDA approval: Website: https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment/drc-20351199
  4. The New York Times – Article discussing the importance of FDA approval for medications: Website: https://www.nytimes.com/2018/08/22/opinion/fda-drug-approval.html
  5. The Wall Street Journal – Article discussing the FDA approval process and its significance for patient safety: Website: https://www.wsj.com/articles/the-fdas-drug-approval-process-doesnt-need-a-cure-1537302677




  • Dr Khadija

    DPT | MS Pain Management | Intra-articular Injec Specialist | Acupuncturist | Cupping Therapist | Oncology Pain Specialist | Certified Chiropractor 🇬🇧 | Medical Writer | Author